India’s health ministry announced Tuesday that some COVID-19 vaccines are likely to receive licenses in the next few weeks and outlined an initial plan to immunize 300 million people. Health officials said three vaccine companies have applied for early approval for emergency use in India: Serum Institute of India, which has been licensed to manufacture